|
|
Other links at Articles > Medical Students |
| 1. |
Amgen Gets Conditional Approval for Vectibix in EU
|
|
|
Amgen Inc said on Wednesday the European Commission granted conditional marketing approval for its drug Vectibix (panitumumab) as a treatment for metastatic colon cancer. Reuters Health Information
|
| 2. |
Ceramide Build-Up to Blame for Cystic Fibrosis Infections
|
|
|
Accumulation of ceramide in the respiratory tract makes cystic fibrosis patients prone to lung infections, the results of an animal study suggest. Furthermore, one enzyme -- acid sphingomyelinase (Asm) -- is in large part responsible for this build-up and could serve as a therapeutic target. Reuters Health Information
|
|
|